These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20811639)

  • 1. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
    Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
    PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
    Naitoh A; Aoyagi Y; Asakura H
    J Gastroenterol Hepatol; 1999 May; 14(5):436-45. PubMed ID: 10355508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma.
    Norton P; Comunale MA; Herrera H; Wang M; Houser J; Wimmerova M; Romano PR; Mehta A
    Proteomics; 2016 Dec; 16(24):3126-3136. PubMed ID: 27650323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Analysis of α-1-Antitrypsin Glycosylation Isoforms in HCC Patients Using LC-HCD-PRM-MS.
    Yin H; Zhu J; Wang M; Yao ZP; Lubman DM
    Anal Chem; 2020 Jun; 92(12):8201-8208. PubMed ID: 32426967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.
    Korekane H; Hasegawa T; Matsumoto A; Kinoshita N; Miyoshi E; Taniguchi N
    Biochim Biophys Acta; 2012 Sep; 1820(9):1405-11. PubMed ID: 22233759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Analysis of Sex-Hormone-Binding Globulin Glycosylation in Liver Diseases by Liquid Chromatography-Mass Spectrometry Parallel Reaction Monitoring.
    Yuan W; Benicky J; Wei R; Goldman R; Sanda M
    J Proteome Res; 2018 Aug; 17(8):2755-2766. PubMed ID: 29972295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.
    West CA; Wang M; Herrera H; Liang H; Black A; Angel PM; Drake RR; Mehta AS
    J Proteome Res; 2018 Oct; 17(10):3454-3462. PubMed ID: 30110170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.
    Wang M; Long RE; Comunale MA; Junaidi O; Marrero J; Di Bisceglie AM; Block TM; Mehta AS
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1914-21. PubMed ID: 19454616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of core fucosylation of serum proteins in liver diseases by LC-MS-MRM.
    Ma J; Sanda M; Wei R; Zhang L; Goldman R
    J Proteomics; 2018 Oct; 189():67-74. PubMed ID: 29427759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
    Tanabe K; Kitagawa K; Kojima N; Iijima S
    J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
    Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
    Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman based hepatocellular carcinoma biomarker detection.
    Santiago-Cordoba MA; Romano PR; MacKay A; Demirel MC
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3672-5. PubMed ID: 22255136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
    Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A procedure for the analysis of site-specific and structure-specific fucosylation in alpha-1-antitrypsin.
    Yin H; Zhu J; Wu J; Tan Z; An M; Zhou S; Mechref Y; Lubman DM
    Electrophoresis; 2016 Oct; 37(20):2624-2632. PubMed ID: 27439567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
    Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
    Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.
    Yin H; Lin Z; Nie S; Wu J; Tan Z; Zhu J; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2887-96. PubMed ID: 24799124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential study of serum glycoprotein fucosylation in acute hepatitis.
    Seta N; Gayno S; Jezequel-Cuer M; Toueg ML; Erlinger S; Durand G
    J Hepatol; 1997 Feb; 26(2):265-71. PubMed ID: 9059945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
    Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
    Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.